Main Menu
Menu

Blog

Publish Date
Blog
Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth

The FDA recently approved a new version of Keytruda, a cancer immunotherapy medicine that is one of the world’s most successful drugs....

BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Blog
Highlights from the October 8 PERA Hearing

On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a hearing on the Patent Eligibility Restoration Act (PERA) to examine...

Blog
Inventor Spotlight: Malcom McLean

C4IP is honoring Malcom McLean (1913-2001), whose invention of containerized shipping revolutionized global trade. Born into a farming family in North Carolina,...

Blog
This Month in IP: September 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From fabric...

Blog
C4IP Coalition Updates: September 2025

September Highlights: C4IP Launches New Website to Correct Patent Misinformation For years, the Initiative for Medicines, Access & Knowledge — better known...

Blog
Inventor Spotlight: John B. Goodenough

This month, C4IP is honoring John B. Goodenough (1922-2023), whose work on the invention of the lithium-ion battery powers billions of high-tech...

Blog
Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA)

This chaotic area of law harms American innovation and competitiveness Without Congressional consideration or endorsement, the Supreme Court has fundamentally altered the...

BlogFact Checks
Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a...

Blog
This Month in IP: August 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From entertainment...

Blog
C4IP Coalition Updates: August 2025

August Highlights: Setting the Record Straight on the DOJ/FTC Listening Sessions The Department of Justice and Federal Trade Commission recently hosted listening...

BlogOp-Eds
To Defend Nations, NATO Must Defend Innovation

In a new piece for Newsweek, Mircea Geoană, former NATO deputy secretary general and president of the Aspen Institute Romania, and Andrei...

Newsweek
Blog:

Blog:

New Resource: Perspectives on IP and Technology Transfer in the United States,

08/29/2023
Blog:

Blog, Fact Checks:

Fact Check: The Patent Eligibility Restoration Act Does Not Allow Patenting of Naturally-Occurring Genes,

08/23/2023
Blog:

Blog:

Celebrating American Innovation: Ralph Baer,

08/16/2023
Op-Eds:

Blog, Op-Eds:

The European Commission is set to undermine the continent’s tech industry,

08/03/2023
Blog:

Blog:

C4IP Coalition Updates: July 2023,

07/31/2023
Blog:

Blog:

This Month in IP: July 2023,

07/31/2023
Blog:

Blog:

The Council for Innovation Promotion (C4IP) and University of Maryland Host Roundtable on PG County Innovation Ecosystem With Rep. Glenn Ivey (MD-4),

07/25/2023
Blog:

Blog:

C4IP Q&A Series: Revisiting Interview with Senator Thom Tillis, Part 2,

07/21/2023
Blog:

Blog:

Celebrating American Innovation: Josephine Cochrane,

07/18/2023
Blog:

Blog:

The Future of AI and IP,

07/13/2023
Blog:

Blog, Fact Checks:

Fact Check: The ITC’s Import Process and Bans Help Protect U.S. Innovators,

07/10/2023
Blog:

Blog:

Why C4IP Supports the PREVAIL Act,

07/05/2023
Scroll to Top